Life is pain: Fibromyalgia as a nexus of multiple liability distributions

Authors:
Publisher website
Google Scholar
Abstract
Fibromyalgia is a complex disease of unclear etiology that is complicated by difficulties in diagnosis, treatment, and clinical heterogeneity. To clarify this etiology, healthcare‐based data are leveraged to assess the influences on fibromyalgia in several domains. Prevalence is less than 1% of females in our population register data, and about 1/10th that in males. Fibromyalgia often presents with co‐occurring conditions including back pain, rheumatoid arthritis, and anxiety. More comorbidities are identified with hospital‐associated biobank data, falling into three broad categories of pain‐related, autoimmune, and psychiatric disorders. Selecting representative phenotypes with published genome‐wide association results for polygenic scoring, we confirm genetic predispositions to psychiatric, pain sensitivity, and autoimmune conditions show associations with fibromyalgia, although these may differ by ancestry group. We conduct a genome‐wide association analysis of fibromyalgia in biobank samples, which did not result in any genome‐wide significant loci; further studies with increased sample size are necessary to identify specific genetic effects on fibromyalgia. Overall, fibromyalgia appears to have strong clinical and likely genetic links to several disease categories, and could usefully be understood as a composite manifestation of these etiological sources.
Funding Information
  • National Institutes of Health (R01MH113362, R56MH120736)
  • Vetenskapsrådet (2016‐01176)

This publication has 53 references indexed in Scilit: